British Journal of Ophthalmology

Papers
(The H4-Index of British Journal of Ophthalmology is 33. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)
ArticleCitations
Ocular manifestations of a hospitalised patient with confirmed 2019 novel coronavirus disease254
European Glaucoma Society Terminology and Guidelines for Glaucoma, 5th Edition170
Artificial intelligence for anterior segment diseases: Emerging applications in ophthalmology106
Characteristics of endothelial corneal transplant rejection following immunisation with SARS-CoV-2 messenger RNA vaccine97
Retinal findings in hospitalised patients with severe COVID-1987
Prospective evaluation of an artificial intelligence-enabled algorithm for automated diabetic retinopathy screening of 30 000 patients83
Treatments for dry age-related macular degeneration: therapeutic avenues, clinical trials and future directions80
Modern approach to the treatment of dry eye, a complex multifactorial disease: a P.I.C.A.S.S.O. board review77
Visual acuity outcomes and anti-VEGF therapy intensity in diabetic macular oedema: a real-world analysis of 28 658 patient eyes75
Myopia incidence and lifestyle changes among school children during the COVID-19 pandemic: a population-based prospective study73
12-year analysis of incidence, microbiological profiles and in vitro antimicrobial susceptibility of infectious keratitis: the Nottingham Infectious Keratitis Study68
Short-term real-world outcomes following intravitreal brolucizumab for neovascular AMD: SHIFT study66
Comparison of widefield swept-source optical coherence tomography angiography with ultra-widefield colour fundus photography and fluorescein angiography for detection of lesions in diabetic retinopath63
COVID-19 and immunosuppression: a review of current clinical experiences and implications for ophthalmology patients taking immunosuppressive drugs57
Convolutional neural network to identify symptomatic Alzheimer’s disease using multimodal retinal imaging54
Gene therapy for neovascular age-related macular degeneration: rationale, clinical trials and future directions53
Retinal microvascular abnormalities in patients after COVID-19 depending on disease severity47
New meaning for NLP: the trials and tribulations of natural language processing with GPT-3 in ophthalmology46
Evolution of therapies for the corneal endothelium: past, present and future approaches46
Retinal age gap as a predictive biomarker for mortality risk45
Corneal confocal microscopy identifies corneal nerve fibre loss and increased dendritic cells in patients with long COVID45
Non-neovascular age-related macular degeneration with subretinal fluid45
Myopia control effect of defocus incorporated multiple segments (DIMS) spectacle lens in Chinese children: results of a 3-year follow-up study43
Choroidal vascularity index: a step towards software as a medical device43
Long-term safety and tolerability of subretinal transplantation of embryonic stem cell-derived retinal pigment epithelium in Asian Stargardt disease patients41
One-year myopia control efficacy of spectacle lenses with aspherical lenslets41
Corneal graft failure: an update39
Automatic interpretation and clinical evaluation for fundus fluorescein angiography images of diabetic retinopathy patients by deep learning39
Comparison of 13 formulas for IOL power calculation with measurements from partial coherence interferometry38
Ophthalmic adverse effects of immune checkpoint inhibitors: the Mayo Clinic experience36
Four-year observation of the changes in corneal endothelium cell density and correlated factors after Implantable Collamer Lens V4c implantation36
Big-data and artificial-intelligence-assisted vault prediction and EVO-ICL size selection for myopia correction35
Microaneurysms visualisation using five different optical coherence tomography angiography devices compared to fluorescein angiography34
Leber congenital amaurosis/early-onset severe retinal dystrophy: current management and clinical trials33
Efficacy and safety of brolucizumab versus aflibercept in eyes with polypoidal choroidal vasculopathy in Japanese participants of HAWK33
0.063873052597046